Biofrontera Inc. (BFRI)
| Previous Close | 1.2400 |
| Open | 1.2500 |
| Bid | 1.2300 x 100 |
| Ask | 1.2900 x 100 |
| Day's Range | 1.2200 - 1.2700 |
| 52 Week Range | 0.6100 - 9.5200 |
| Volume | |
| Avg. Volume | 175,320 |
| Market Cap | 6.985M |
| Beta (5Y Monthly) | 0.47 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -2.7400 |
| Earnings Date | Nov 09, 2024 - Nov 24, 2024 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 11.50 |
Simply Wall St.Biofrontera Second Quarter 2024 Earnings: EPS Beats Expectations, Revenues Lag
Biofrontera ( NASDAQ:BFRI ) Second Quarter 2024 Results Key Financial Results Revenue: US$7.84m (up 34% from 2Q 2023...
GlobeNewswireBiofrontera Inc. Reports Second Quarter 2024 Financial Results and Provides a Business Update
Woburn, MA, Aug. 14, 2024 (GLOBE NEWSWIRE) -- Biofrontera Inc. (NASDAQ:BFRI) (the "Company"), a biopharmaceutical company specializing in the commercialization of dermatologic products, today reported financial results for the three and six months ended June 30, 2024 and provided a business update. Highlights from the second quarter of 2024 and subsequent weeks included the following: Total revenues for the second quarter of 2024 were $7.8 million, a 34% increase from the same period of the prio
ACCESSWIREBiofrontera Inc. to Report Second Quarter Financial Results on August 14, 2024
WOBURN, MA / ACCESSWIRE / August 9, 2024 / Biofrontera Inc. (Nasdaq:BFRI), a biopharmaceutical company specializing in the commercialization of dermatological products, announces it will report financial results for the three and six months ended ...
